menu_open
Lisa Jarvis

Lisa Jarvis

The Japan Times

We use cookies to provide some features and experiences in QOSHE

More information  .  Close

Insurers can’t avoid covering weight-loss drugs forever

New data illustrating the health benefits of Novo Nordisk’s obesity drug Wegovy puts insurers in the increasingly uncomfortable position of...

18.08.2023 90

The Japan Times

Lisa Jarvis

Women are drinking more alcohol and it’s killing them

New data show that more U.S. women are dying from alcohol than ever before. Public health authorities need to adopt more effective strategies to help...

18.08.2023 80

The Japan Times

Lisa Jarvis

Women are drinking more alcohol and it’s killing them

New data show that more U.S. women are dying from alcohol than ever before. Public health authorities need to adopt more effective strategies to help...

18.08.2023 20

The Japan Times

Lisa Jarvis

New postpartum depression pill is a vital breakthrough

The landmark approval of the first pill for postpartum depression offers an important new treatment for the 1 in 7 new mothers who experience the...

09.08.2023 80

The Japan Times

Lisa Jarvis

Eli Lilly’s new weight-loss drug is even better than Ozempic

New data from an experimental drug being developed by Eli Lilly & Co. raises an intriguing question about obesity treatments: How low can the weight...

28.06.2023 70

The Japan Times

Lisa Jarvis

Eradicate breast cancer? The hunt for a vaccine looks promising

Imagine a future where far fewer women are diagnosed with breast cancer, and women with a family history of breast cancer don’t have to make the...

23.06.2023 80

The Japan Times

Lisa Jarvis

Yet another bad week for abortion rights in America

It’s been almost 11 months since the U.S. Supreme Court overturned Roe v. Wade and access to abortion just keeps getting worse. Last week alone saw...

24.05.2023 70

The Japan Times

Lisa Jarvis

Xylazine spreads faster than U.S. officials can act

The U.S. Drug Enforcement Administration recently issued a warning about a drug that’s making the nation’s deadly opioid epidemic even deadlier....

22.05.2023 30

The Japan Times

Lisa Jarvis

Bats, cheetahs and hippos unlock mysteries of the human genome

Humans like to think we have a monopoly on understanding ourselves — that explanations for all our inner workings, including when things go awry,...

19.05.2023 10

The Japan Times

Lisa Jarvis

A breakthrough on Alzheimer’s is closer than ever

New data for Eli Lilly & Co.’s Alzheimer’s treatment donanemab is a big win for patients and their families after decades of disappointments....

17.05.2023 20

The Japan Times

Lisa Jarvis

Cancer vaccine hunt makes progress, finally

The long-awaited cancer vaccine revolution is getting a little closer to reality. New data from Moderna Inc. and Merck & Co. suggest that after...

21.04.2023 20

The Japan Times

Lisa Jarvis

Abortion pill rulings to impact pharmaceutical innovation

A Texas federal judge’s ruling to remove the 23-year old drug mifepristone from the market not only threatens abortion access in the U.S. — it’s...

19.04.2023 20

The Japan Times

Lisa Jarvis

Schizophrenia drug may offer much-needed progress

Next year, doctors might finally have something new to offer people who suffer from schizophrenia: a much-needed drug that can better improve their...

12.04.2023 10

The Japan Times

Lisa Jarvis

Obesity drugs for kids? Why new guidelines make sense

A leading organization of pediatricians is recommending that teens with obesity be offered weight-loss medication as part of a comprehensive treatment...

08.03.2023 10

The Japan Times

Lisa Jarvis

A refreshing gamble on Crispr delivery

For years, we’ve known that genetic diseases could one day be cured by technologies like Crispr. But there has always been a catch: These...

27.02.2023 20

The Japan Times

Lisa Jarvis

The U.S. needs five times as many child psychiatrists

Between falling test scores and rising rates of mental illness, U.S. kids are not alright. COVID-19 is an easy villain, but signs of strain were...

13.02.2023 20

The Japan Times

Lisa Jarvis

Don’t write off the retooled COVID-19 boosters

Two new, small studies are stirring up more controversy over the new COVID-19 boosters, updated to match the omicron BA.4 and BA.5 strains. The...

11.01.2023 20

The Japan Times

Lisa Jarvis

Cancer vaccine hunt finally makes progress

The long-awaited cancer vaccine revolution is getting a little closer to reality. New data from Moderna Inc. and Merck & Co. suggest that after...

04.01.2023 30

The Japan Times

Lisa Jarvis

6b1790573addf393994ffa9d712149be